8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

 Current Report

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): October 19, 2022

  LAM RESEARCH CORPORATION

(Exact name of registrant as specified in its charter)

Delaware	0-12933	94-2634797
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification Number)

4650 Cushing Parkway

Fremont, California 94538

(Address of principal executive offices including zip code)

(510) 572-0200

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol	Name of each exchange on which registered
Common Stock, Par Value $0.001 Per Share	LRCX	The Nasdaq Stock Market
		(Nasdaq Global Select Market)

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company      ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.                      ☐

Table of Contents

Item 2.02.	Results of Operations and Financial Condition	3
Item 9.01.	Financial Statements and Exhibits	3
SIGNATURES		4
EX-99.1

 Item 2.02. Results of Operations and Financial Condition

On October 19, 2022, Lam Research Corporation (the “Company”) issued a press release announcing its financial results for the fiscal quarter ended September 25, 2022, the text of which is attached hereto as Exhibit 99.1.

The information in this item of this Current Report on Form 8-K, including Exhibit 99.1, is furnished pursuant to Item 2.02 and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under that Section. Furthermore, the information in this item of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Exchange Act.

 Item 9.01. Financial Statements and Exhibits

(d) Exhibits

99.1	Press Release dated October 19, 2022 announcing financial results for the fiscal quarter ended September 25, 2022
104	Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date:	October 19, 2022	LAM RESEARCH CORPORATION
		(Registrant)
		/s/ Douglas R. Bettinger
		Douglas R. Bettinger
		Executive Vice President, Chief Financial Officer
		(Principal Financial Officer and Principal Accounting Officer)

EX-99.1

Exhibit 99.1

FOR IMMEDIATE RELEASE

Lam Research Corporation Reports Financial Results for the Quarter Ended September 25, 2022

FREMONT, Calif., October 19, 2022 - Lam Research Corporation (the "Company," "Lam," "Lam Research") today announced financial results for the quarter ended September 25, 2022 (the “September 2022 quarter”).

Highlights for the September 2022 quarter were as follows:

•Revenue of $5.07 billion.

•U.S. GAAP gross margin of 46.1%, U.S. GAAP operating income as a percentage of revenue of 33.5%, and U.S. GAAP diluted EPS of $10.39.

•Non-GAAP gross margin of 46.0%, non-GAAP operating income as a percentage of revenue of 33.3%, and non-GAAP diluted EPS of $10.42.

Key Financial Data for the Quarters Ended

September 25, 2022 and June 26, 2022

(in thousands, except per-share data, percentages, and basis points)

U.S. GAAP
	September 2022			June 2022			Change Q/Q
Revenue	$	5,074,121		$	4,635,554		+ 9.5%
Gross margin as percentage of revenue	46.1		%	45.3		%	+ 80 bps
Operating income as percentage of revenue	33.5		%	31.9		%	+ 160 bps
Diluted EPS	$	10.39		$	8.74		+ 18.9%
Non-GAAP
	September 2022			June 2022			Change Q/Q
Revenue	$	5,074,121		$	4,635,554		+ 9.5%
Gross margin as percentage of revenue	46.0		%	45.2		%	+ 80 bps
Operating income as percentage of revenue	33.3		%	31.5		%	+ 180 bps
Diluted EPS	$	10.42		$	8.83		+ 18.0%

U.S. GAAP Financial Results

For the September 2022 quarter, revenue was $5,074 million, gross margin was $2,337 million, or 46.1% of revenue, operating expenses were $639 million, operating income was 33.5% of revenue, and net income was $1,426 million, or $10.39 per diluted share on a U.S. GAAP basis. This compares to revenue of $4,636 million, gross margin of $2,101 million, or 45.3% of revenue, operating expenses of $621 million, operating income of 31.9% of revenue, and net income of $1,209 million, or $8.74 per diluted share, for the quarter ended June 26, 2022 (the “June 2022 quarter”).

Non-GAAP Financial Results

For the September 2022 quarter, non-GAAP gross margin was $2,335 million, or 46.0% of revenue, non-GAAP operating expenses were $647 million, non-GAAP operating income was 33.3% of revenue, and non-GAAP net income was $1,429 million, or $10.42 per diluted share. This compares to non-GAAP gross margin of $2,094 million, or 45.2% of revenue, non-GAAP operating expenses of $635 million, non-GAAP operating income of 31.5% of revenue, and non-GAAP net income of $1,221 million, or $8.83 per diluted share, for the June 2022 quarter.

“Lam exceeded $5 billion in revenue in the September quarter, an all-time record. Solid execution combined with easing supply chain conditions produced strong overall performance,” said Tim Archer, Lam Research’s President and Chief Executive Officer. “While we expect weaker wafer fabrication equipment spending in 2023, our technology leadership and demonstrated track record of managing through downturns provide us a strong foundation to capture the exciting opportunities ahead for the semiconductor industry.”

Balance Sheet and Cash Flow Results

Cash and cash equivalents, short-term investments, and restricted cash and investments balances increased to $4.6 billion at the end of the September 2022 quarter compared to $3.9 billion at the end of the June 2022 quarter. This increase was primarily the result of $1,190 million of cash generated from operating activities, partially offset by $206 million of dividends paid to stockholders; $140 million of capital expenditures; and $110 million of share repurchases, including net share settlement of employee stock-based compensation.

Deferred revenue at the end of the September 2022 quarter increased to $2,755 million compared to $2,198 million as of the end of the June 2022 quarter. Lam's deferred revenue balance does not include shipments to customers in Japan, to whom title does not transfer until customer acceptances. Shipments to customers in Japan are classified as inventory at cost until the time of acceptance. The estimated future revenue from shipments to customers in Japan was approximately $401 million as of September 25, 2022 and $367 million as of June 26, 2022.

Revenue

The geographic distribution of revenue during the September 2022 quarter is shown in the following table:

Region	Revenue
China	30%
Taiwan	22%
Korea	17%
Southeast Asia	11%
Japan	9%
United States	6%
Europe	5%

The following table presents revenue disaggregated between system and customer support-related revenue:

	Three Months Ended
	September 25, 2022		June 26, 2022		September 26, 2021
	(In thousands)
System revenue	$	3,181,987	$	3,006,374	$	2,924,883
Customer support-related revenue and other	1,892,134		1,629,180		1,379,582
	$	5,074,121	$	4,635,554	$	4,304,465

System revenue includes sales of new leading-edge equipment in deposition, etch and clean markets.

Customer support-related revenue includes sales of customer service, spares, upgrades, and non-leading-edge equipment from our Reliant® product line.

Outlook

For the quarter ended December 25, 2022, Lam is providing the following guidance:

	U.S. GAAP			Reconciling Items			Non-GAAP
Revenue	$5.1 Billion	+/-	$300 Million	—			$5.1 Billion	+/-	$300 Million
Gross margin as a percentage of revenue	44.5%	+/-	1%	$	1	Million	44.5%	+/-	1%
Operating income as a percentage of revenue	31.5%	+/-	1%	$	3	Million	31.5%	+/-	1%
Net income per diluted share	$9.98	+/-	$0.75	$	3	Million	$10.00	+/-	$0.75
Diluted share count	136 Million			—			136 Million

The information provided above is only an estimate of what the Company believes is realizable as of the date of this release and does not incorporate the potential impact of any business combinations, asset acquisitions, divestitures, restructuring, balance sheet valuation adjustments, financing arrangements, other investments, or other significant arrangements that may be completed or recognized after the date of this release. U.S. GAAP to non-GAAP reconciling items provided include only those items that are known and can be estimated as of the date of this release. Actual results will vary from this model and the variations may be material. Reconciling items included above are as follows:

•Gross margin as a percentage of revenue - amortization related to intangible assets acquired through business combinations, $1 million.

•Operating income as a percentage of revenue - amortization related to intangible assets acquired through business combinations, $3 million.

•Net income per diluted share - amortization related to intangible assets acquired though business combinations, $3 million; amortization of note discounts, $1 million; and associated tax benefit for non-GAAP items ($1 million); totaling $3 million.

Use of Non-GAAP Financial Results

In addition to U.S. GAAP results, this press release also contains non-GAAP financial results. The Company’s non-GAAP results for both the September 2022 and June 2022 quarters exclude amortization related to intangible assets acquired through business combinations, the effects of elective deferred compensation-related assets and liabilities, amortization of note discounts, and the net income tax effect of non-GAAP items.

Management uses non-GAAP gross margin, operating expense, operating income, operating income as a percentage of revenue, net income, and net income per diluted share to evaluate the Company’s operating and financial results. The Company believes the presentation of non-GAAP results is useful to investors for analyzing business trends and comparing performance to prior periods, along with enhancing investors’ ability to view the Company’s results from management’s perspective. Tables presenting reconciliations of non-GAAP results to U.S. GAAP results are included at the end of this press release and on the Company’s website at https://investor.lamresearch.com.

Caution Regarding Forward-Looking Statements

Statements made in this press release that are not of historical fact are forward-looking statements and are subject to the safe harbor provisions created by the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relate to, but are not limited to: our outlook and guidance for future financial results, including revenue, gross margin, operating income and net income; our expectations for wafer fabrication equipment spending; our technology leadership; and the opportunities ahead for the semiconductor industry and our ability to capture those opportunities. Some factors that may affect these forward-looking statements include: trade regulations, export controls, trade disputes, and other geopolitical tensions may inhibit our ability to sell our products; supply chain disruptions have limited and are expected to continue to limit our ability to meet demand for our products; supply chain cost increases and other inflationary pressures have impacted and are expected to continue to impact our profitability; business, political and/or regulatory conditions in the consumer electronics industry, the semiconductor industry and the overall economy may deteriorate or change; the actions of our customers and competitors may be inconsistent with our expectations; the severity, magnitude and duration of the COVID–19 pandemic (and the related governmental, public health, business and community responses to it), and their impacts on our business, results of operations and financial condition, are evolving and are highly uncertain and unpredictable; and widespread outbreaks of illness may impact our operations and revenue in affected areas; as well as the other risks and uncertainties that are described in the documents filed or furnished by us with the Securities and Exchange Commission, including specifically the Risk Factors described in our annual report on Form 10–K for the fiscal year ended June 26, 2022. These uncertainties and changes could materially affect the forward-looking statements and cause actual results to vary from expectations in a material way. The Company undertakes no obligation to update the information or statements made in this release.

Lam Research Corporation is a global supplier of innovative wafer fabrication equipment and services to the semiconductor industry. Lam's equipment and services allow customers to build smaller and better performing devices. In fact, today, nearly every advanced chip is built with Lam technology. We combine superior systems engineering, technology leadership, and a strong values-based culture, with an unwavering commitment to our customers. Lam Research (Nasdaq: LRCX) is a FORTUNE 500® company headquartered in Fremont, Calif., with operations around the globe. Learn more at www.lamresearch.com. (LRCX-F)

Consolidated Financial Tables Follow.

###

LAM RESEARCH CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data and percentages)

(unaudited)

	Three Months Ended
	September 25, 2022			June 26, 2022			September 26, 2021
Revenue	$	5,074,121		$	4,635,554		$	4,304,465
Cost of goods sold	2,737,286			2,535,042			2,327,711
Gross margin	2,336,835			2,100,512			1,976,754
Gross margin as a percent of revenue	46.1		%	45.3		%	45.9		%
Research and development	433,375			411,157			382,327
Selling, general and administrative	205,620			210,002			222,194
Total operating expenses	638,995			621,159			604,521
Operating income	1,697,840			1,479,353			1,372,233
Operating income as a percent of revenue	33.5		%	31.9		%	31.9		%
Other income (expense), net	(43,095)			(120,448)			(28,857)
Income before income taxes	1,654,745			1,358,905			1,343,376
Income tax expense	(228,866)			(149,971)			(163,632)
Net income	$	1,425,879		$	1,208,934		$	1,179,744
Net income per share:
Basic	$	10.42		$	8.76		$	8.32
Diluted	$	10.39		$	8.74		$	8.27
Number of shares used in per share calculations:
Basic	136,891			137,993			141,743
Diluted	137,208			138,313			142,612
Cash dividend declared per common share	$	1.725		$	1.50		$	1.50

LAM RESEARCH CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands)

	September 25, 2022		June 26, 2022		September 26, 2021
	(unaudited)		(1)		(unaudited)
ASSETS
Cash and cash equivalents	$	4,256,499	$	3,522,001	$	4,042,151
Investments	120,551		135,731		569,472
Accounts receivable, net	4,569,735		4,313,818		3,397,180
Inventories	4,360,325		3,966,294		2,872,141
Prepaid expenses and other current assets	305,554		347,391		263,738
Total current assets	13,612,664		12,285,235		11,144,682
Property and equipment, net	1,718,791		1,647,587		1,372,533
Restricted cash and investments	250,955		251,534		251,448
Goodwill and intangible assets	1,624,932		1,616,963		1,614,959
Other assets	1,513,940		1,394,313		1,181,930
Total assets	$	18,721,282	$	17,195,632	$	15,565,552
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current portion of long-term debt and finance lease obligations	$	7,110	$	7,381	$	6,368
Other current liabilities	5,046,272		4,557,378		3,402,852
Total current liabilities	5,053,382		4,564,759		3,409,220
Long-term debt and finance lease obligations	4,996,363		4,998,449		4,988,964
Income taxes payable	840,214		931,117		881,325
Other long-term liabilities	418,756		422,941		466,000
Total liabilities	11,308,715		10,917,266		9,745,509
Stockholders’ equity (2)	7,412,567		6,278,366		5,820,043
Total liabilities and stockholders’ equity	$	18,721,282	$	17,195,632	$	15,565,552

(1)	Derived from audited financial statements.
(2)	Common shares issued and outstanding were 136,374 as of September 25, 2022, 136,975 as of June 26, 2022, and 140,811 as of September 26, 2021.

LAM RESEARCH CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands, unaudited)

	Three Months Ended
	September 25, 2022		June 26, 2022		September 26, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$	1,425,879	$	1,208,934	$	1,179,744
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	75,751		87,932		79,874
Deferred income taxes	(133,616)		(173,987)		(13,023)
Equity-based compensation expense	71,110		69,588		58,099
Other, net	(2,751)		33,574		(8,690)
Changes in operating assets and liabilities	(246,785)		(782,107)		(838,480)
Net cash provided by operating activities	1,189,588		443,934		457,524
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures and intangible assets	(140,063)		(125,746)		(136,427)
Net maturities and sales of available-for-sale securities	14,695		23,486		738,043
Other, net	(2,435)		26,323		(4,923)
Net cash (used for) provided by investing activities	(127,803)		(75,937)		596,693
CASH FLOWS FROM FINANCING ACTIVITIES:
Principal payments on debt	(1,854)		(2,032)		(6,338)
Treasury stock purchases	(109,779)		(876,089)		(1,236,753)
Dividends paid	(205,615)		(208,056)		(185,431)
Reissuance of treasury stock related to employee stock purchase plan	—		61,798		—
Proceeds from issuance of common stock	6,796		997		742
Other, net	(489)		(152)		188
Net cash used for financing activities	(310,941)		(1,023,534)		(1,427,592)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	(16,925)		(16,683)		(3,776)
Net increase (decrease) in cash, cash equivalents, and restricted cash	733,919		(672,220)		(377,151)
Cash, cash equivalents, and restricted cash at beginning of period	3,773,535		4,445,755		4,670,750
Cash, cash equivalents, and restricted cash at end of period	$	4,507,454	$	3,773,535	$	4,293,599

Non-GAAP Financial Summary

(in thousands, except percentages and per share data)

(unaudited)

	Three Months Ended
	September 25, 2022			June 26, 2022
Revenue	$	5,074,121		$	4,635,554
Gross margin	$	2,335,168		$	2,094,006
Gross margin as percentage of revenue	46.0		%	45.2		%
Operating expenses	$	647,239		$	634,631
Operating income	$	1,687,929		$	1,459,375
Operating income as a percentage of revenue	33.3		%	31.5		%
Net income	$	1,429,495		$	1,221,257
Net income per diluted share	$	10.42		$	8.83
Shares used in per share calculation - diluted	137,208			138,313

Reconciliation of U.S. GAAP Net Income to Non-GAAP Net Income

(in thousands, except per share data)

(unaudited)

	Three Months Ended
	September 25, 2022		June 26, 2022
U.S. GAAP net income	$	1,425,879	$	1,208,934
Pre-tax non-GAAP items:
Amortization related to intangible assets acquired through certain business combinations - cost of goods sold	1,451		1,308
Elective deferred compensation ("EDC") related liability valuation decrease - cost of goods sold	(3,118)		(7,814)
EDC related liability valuation decrease - research and development	(5,612)		(14,065)
Amortization related to intangible assets acquired through certain business combinations - selling, general and administrative	1,110		9,969
EDC related liability valuation decrease - selling, general and administrative	(3,742)		(9,376)
Amortization of note discounts - other income (expense), net	707		701
Loss on EDC related asset - other income (expense), net	12,726		32,316
Net income tax expense (benefit) on non-GAAP items	94		(716)
Non-GAAP net income	$	1,429,495	$	1,221,257
Non-GAAP net income per diluted share	$	10.42	$	8.83
U.S. GAAP net income per diluted share	$	10.39	$	8.74
U.S. GAAP and non-GAAP number of shares used for per diluted share calculation	137,208		138,313

Reconciliation of U.S. GAAP Gross Margin, Operating Expenses and Operating Income to Non-GAAP Gross Margin, Operating Expenses and Operating Income

(in thousands, except percentages)

(unaudited)

	Three Months Ended
	September 25, 2022			June 26, 2022
U.S. GAAP gross margin	$	2,336,835		$	2,100,512
Pre-tax non-GAAP items:
Amortization related to intangible assets acquired through certain business combinations	1,451			1,308
EDC related liability valuation decrease	(3,118)			(7,814)
Non-GAAP gross margin	$	2,335,168		$	2,094,006
U.S. GAAP gross margin as a percentage of revenue	46.1		%	45.3		%
Non-GAAP gross margin as a percentage of revenue	46.0		%	45.2		%
U.S. GAAP operating expenses	$	638,995		$	621,159
Pre-tax non-GAAP items:
Amortization related to intangible assets acquired through certain business combinations	(1,110)			(9,969)
EDC related liability valuation decrease	9,354			23,441
Non-GAAP operating expenses	$	647,239		$	634,631
U.S. GAAP operating income	$	1,697,840		$	1,479,353
Non-GAAP operating income	$	1,687,929		$	1,459,375
U.S. GAAP operating income as percent of revenue	33.5		%	31.9		%
Non-GAAP operating income as a percent of revenue	33.3		%	31.5		%

Lam Research Corporation Contacts:

Tina Correia, Investor Relations, phone: 510-572-1615, e-mail: investor.relations@lamresearch.com

XML

Cover page	Oct. 19, 2022
Cover [Abstract]
Document Type	8-K
Document Period End Date	Oct. 19, 2022
Entity Registrant Name	LAM RESEARCH CORPORATION
Entity Incorporation, State or Country Code	DE
Entity File Number	0-12933
Entity Tax Identification Number	94-2634797
Entity Address, Address Line One	4650 Cushing Parkway
Entity Address, City or Town	Fremont
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94538
City Area Code	510
Local Phone Number	572-0200
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Title of 12(b) Security	Common Stock, Par Value $0.001 Per Share
Trading Symbol	LRCX
Security Exchange Name	NASDAQ
Entity Emerging Growth Company	false
Amendment Flag	false
Entity Central Index Key	0000707549